Advertisement

Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI

  • Mingzan Zhuang
  • Nicolas A. Karakatsanis
  • Rudi A. J. O. Dierckx
  • Habib ZaidiEmail author
Research Article
  • 27 Downloads

Abstract

Purpose

The aim of this work is to investigate the impact of tissue classification in magnetic resonance imaging (MRI)-guided positron emission tomography (PET) attenuation correction (AC) for whole-body (WB) Patlak net uptake rate constant (Ki) imaging in PET/MRI studies.

Procedures

WB dynamic PET/CT data were acquired for 14 patients. The CT images were utilized to generate attenuation maps (μ-mapCTAC) of continuous attenuation coefficient values (Acoeff). The μ-mapCTAC were then segmented into four tissue classes (μ-map4-classes), namely background (air), lung, fat, and soft tissue, where a predefined Acoeff was assigned to each class. To assess the impact of bone for AC, the bones in the μ-mapCTAC were then assigned a predefined soft tissue Acoeff (0.1 cm−1) to produce an AC μ-map without bones (μ-mapno-bones). Thereafter, both WB static SUV and dynamic PET images were reconstructed using μ-mapCTAC, μ-map4-classes, and μ-mapno-bones (PETCTAC, PET4-classes, and PETno-bones), respectively. WB indirect and direct parametric Ki images were generated using Patlak graphical analysis. Malignant lesions were delineated on PET images with an automatic segmentation method that uses an active contour model (MASAC). Then, the quantitative metrics of the metabolically active tumor volume (MATV), target-to-background (TBR), contrast-to-noise ratio (CNR), peak region-of-interest (ROIpeak), maximum region-of-interest (ROImax), mean region-of-interest (ROImean), and metabolic volume product (MVP) were analyzed. The Wilcoxon test was conducted to assess the difference between PET4-classes and PETno-bones against PETCTAC for all images. The same test was also adopted to compare the differences between SUV, indirect Ki, and direct Ki images for each evaluated AC method.

Results

No significant differences in MATV, TBR, and CNR were observed between PET4-classes and PETCTAC for either SUV or Ki images. PET4-classes significantly overestimated ROIpeak, ROImax, ROImean, as well as MVP scores compared with PETCTAC in both SUV and Ki images. SUV images exhibited the highest median relative errors for PET4-classes with respect to PETCTAC (RE4-classes): 6.91 %, 6.55 %, 5.90 %, and 6.56 % for ROIpeak, ROImax, ROImean, and MVP, respectively. On the contrary, Ki images showed slightly reduced RE4-classes (indirect 5.52 %, 5.95 %, 4.43 %, and 5.70 %, direct 6.61 %, 6.33 %, 5.53 %, and 4.96 %) for ROIpeak, ROImax, ROImean, and MVP, respectively. A higher TBR was observed on indirect and direct Ki images relative to SUV, while direct Ki images demonstrated the highest CNR.

Conclusions

Four-tissue class AC may impact SUV and Ki parameter estimation but only to a limited extent, thereby suggesting that WB Patlak Ki imaging for dynamic WB PET/MRI studies is feasible. Patlak Ki imaging can enhance TBR, thereby facilitating lesion segmentation and quantification. However, patient-specific Acoeff for each tissue class should be used when possible to address the high inter-patient variability of Acoeff distributions.

Key words

Whole-body PET/MRI SUV Patlak analysis Tissue classification Attenuation correction 

Notes

Acknowledgments

The authors would like to thank Prof. Ronald Boellaard, Prof. Qingchun Qiu, and Zemian Chen for their assistance.

Funding Information

This work was supported by the Swiss National Science Foundation under grant no. SNSF 320030_176052 and the Swiss Cancer Research Foundation under Grant KFS-3855-02-2016.

Compliance with Ethical Standards

The study was approved by the local ethics committee.

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

11307_2019_1338_MOESM1_ESM.pdf (436 kb)
ESM 1 (PDF 436 kb)

References

  1. 1.
    Zaidi H, Becker M (2016) The promise of hybrid PET/MRI: technical advances and clinical applications. IEEE Sign Proc Mag 33:67–85CrossRefGoogle Scholar
  2. 2.
    Cho N, Im SA, Cheon GJ, Park IA, Lee KH, Kim TY, Kim YS, Kwon BR, Lee JM, Suh HY, Suh KJ (2018) Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging 45:328–339CrossRefGoogle Scholar
  3. 3.
    Plecha DM, Faulhaber P (2017) PET/MRI of the breast. Eur J Radiol 94:A26–A34CrossRefGoogle Scholar
  4. 4.
    Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W (2016) PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Eur J Radiol 85:751–759CrossRefGoogle Scholar
  5. 5.
    Lee DH, Lee JM, Hur BY, Joo I, Yi NJ, Suh KS, Kang KW, Han JK (2016) Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging. Radiology 280:782–792CrossRefGoogle Scholar
  6. 6.
    Becker M, Varoquaux AD, Combescure C, Rager O, Pusztaszeri M, Burkhardt K, Delattre BMA, Dulguerov P, Dulguerov N, Katirtzidou E, Caparrotti F, Ratib O, Zaidi H, Becker CD (2018) Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences. Eur Radiol 28:651–663CrossRefGoogle Scholar
  7. 7.
    Mehranian A, Arabi H, Zaidi H (2016) Vision 20/20: magnetic resonance imaging-guided attenuation correction in PET/MRI: challenges, solutions, and opportunities. Med Phys 43:1130–1155CrossRefGoogle Scholar
  8. 8.
    Martinez-Möller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 50:520–526CrossRefGoogle Scholar
  9. 9.
    Kim JH, Lee JS, Song IC, Lee DS (2012) Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med 53:1878–1882CrossRefGoogle Scholar
  10. 10.
    Arabi H, Zaidi H (2016) Magnetic resonance imaging-guided attenuation correction in whole-body PET/MRI using a sorted atlas approach. Med Image Anal 31:1–15CrossRefGoogle Scholar
  11. 11.
    Burgos N, Cardoso MJ, Thielemans K, Modat M, Dickson J, Schott JM, Atkinson D, Arridge SR, Hutton BF, Ourselin S (2015) Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers. Eur J Nucl Med Mol Imaging 42:1447–1458CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Mehranian A, Zaidi H (2015) Joint estimation of activity and attenuation in whole-body TOF PET/MRI using constrained Gaussian mixture models. IEEE Trans Med Imaging 34:1808–1821CrossRefGoogle Scholar
  13. 13.
    Rezaei A, Deroose CM, Vahle T, Boada F, Nuyts J (2018) Joint reconstruction of activity and attenuation in time-of-flight PET: a quantitative analysis. J Nucl Med 59:1624–1629CrossRefGoogle Scholar
  14. 14.
    Keereman V, Van Holen R, Mollet P, Vandenberghe S (2011) The effect of errors in segmented attenuation maps on PET quantification. Med Phys 38:6010–6019CrossRefGoogle Scholar
  15. 15.
    Akbarzadeh A, Ay MR, Ahmadian A, Alam NR, Zaidi H (2013) MRI-guided attenuation correction in whole-body PET/MR: assessment of the effect of bone attenuation. Ann Nucl Med 27:152–162CrossRefGoogle Scholar
  16. 16.
    Arabi H, Rager O, Alem A, Varoquaux A, Becker M, Zaidi H (2015) Clinical assessment of MR-guided 3-class and 4-class attenuation correction in PET/MR. Mol Imaging Biol 17:1–13CrossRefGoogle Scholar
  17. 17.
    Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A (2013) Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application. Phys Med Biol 58:7391–7418CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Karakatsanis NA, Lodge MA, Zhou Y, Wahl RL, Rahmim A (2013) Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation. Phys Med Biol 58:7419–7445CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Karakatsanis NA, Casey ME, Lodge MA, Rahmim A, Zaidi H (2016) Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction. Phys Med Biol 61:5456–5485CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Zaidi H, Karakatsanis N (2018) Towards enhanced PET quantification in clinical oncology. Br J Radiol 91:20170508CrossRefGoogle Scholar
  21. 21.
    Zhuang M, Karakatsanis NA, Dierckx R, Zaidi H (2019) Quantitative analysis of heterogeneous 18F-FDG static (SUV) vs. Patlak (Ki) whole-body PET imaging using different segmentation methods: a simulation study. Mol Imaging Biol.  https://doi.org/10.1007/s11307-018-1241-8
  22. 22.
    Rahmim A, Lodge MA, Karakatsanis NA et al (2019) Dynamic whole-body PET imaging: principles, potentials and applications. Eur J Nucl Med Mol Imaging.  https://doi.org/10.1007/s00259-018-4153-6
  23. 23.
    Fahrni G, Karakatsanis N, Di Domenicantonio G, Garibotto V, Zaidi H (2019) Does whole-body Patlak 18F-FDG PET imaging improve lesion detectability in clinical oncology? Eur Radiol  https://doi.org/10.1007/s00330-018-5966-1
  24. 24.
    Karakatsanis NA, Zhou Y, Lodge MA, Casey ME, Wahl RL, Zaidi H, Rahmim A (2015) Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET. Phys Med Biol 60:8643–8673CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Carney JP, Townsend DW, Rappoport V, Bendriem B (2006) Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys 33:976–983CrossRefGoogle Scholar
  26. 26.
    Tsoumpas C, Thielemans K (2009) Direct parametric reconstruction from dynamic projection data in emission tomography including prior estimation of the blood volume component. Nucl Med Commun 30:490–493CrossRefGoogle Scholar
  27. 27.
    Karakatsanis NA, Mehranian A, Casey ME, Zaidi H (2016) Direct 4D slice-wise whole-body parametric PET image reconstruction for continuous bed motion acquisitions. IEEE Nuclear Science Symposium & Medical Imaging Conference, Strasbourg, France, 29 October – 6 November 2016, pp 1–6Google Scholar
  28. 28.
    Zhuang M, Dierckx RA, Zaidi H (2016) Generic and robust method for automatic segmentation of PET images using an active contour model. Med Phys 43:4483–4494CrossRefGoogle Scholar
  29. 29.
    Tixier F, Vriens D, Cheze-Le Rest C et al (2016) Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in non-small cell lung cancer. J Nucl Med 57:1033–1039CrossRefGoogle Scholar
  30. 30.
    Karakatsanis N, Lodge M, Fahrni G et al (2016) Simultaneous SUV/Patlak-4D whole-body PET: a multi-parametric 4D imaging framework for routine clinical application [abstract]. J Nucl Med 57:367CrossRefGoogle Scholar
  31. 31.
    Ouyang J, Chun SY, Petibon Y, Bonab AA, Alpert N, El Fakhri G (2013) Bias atlases for segmentation-based PET attenuation correction using PET-CT and MR. IEEE Trans Nucl Sci 60:3373–3382CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Karakatsanis N, Tsoumpas C, Zaidi H (2015) The impact of MR-guided PET attenuation correction on whole-body dynamic and parametric PET imaging [abstract]. J Nucl Med 56:1796Google Scholar
  33. 33.
    Robinson PJ, Kreel L (1979) Pulmonary tissue attenuation with computed tomography: comparison of inspiration and expiration scans. J Comput Assist Tomogr 3:740–748CrossRefGoogle Scholar
  34. 34.
    Owrangi AM, Greer PB, Glide-Hurst CK (2018) MRI-only treatment planning: benefits and challenges. Phys Med Biol 63:05TR01CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Arabi H, Dowling JA, Burgos N, Han X, Greer PB, Koutsouvelis N, Zaidi H (2018) Comparative study of algorithms for synthetic CT generation from MRI: consequences for MRI-guided radiation planning in the pelvic region. Med Phys 45:5218–5233CrossRefGoogle Scholar
  36. 36.
    Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha N, Börnert P, Perkuhn M, Niendorf T, Schäfer WM, Brockmann H, Krohn T, Buhl A, Günther RW, Mottaghy FM, Krombach GA (2011) Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 38:138–152CrossRefGoogle Scholar
  37. 37.
    Berker Y, Franke J, Salomon A, Palmowski M, Donker HCW, Temur Y, Mottaghy FM, Kuhl C, Izquierdo-Garcia D, Fayad ZA, Kiessling F, Schulz V (2012) MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med 53:796–804CrossRefGoogle Scholar
  38. 38.
    Sekine T, Ter Voert EE, Warnock G et al (2016) Clinical evaluation of ZTE attenuation correction for brain FDG-PET/MR imaging-comparison with atlas attenuation correction. J Nucl Med 57:1927–1932CrossRefGoogle Scholar
  39. 39.
    Avigaëlle S, Franck L, Pacôme F et al (2016) For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Res 6:1–6CrossRefGoogle Scholar

Copyright information

© World Molecular Imaging Society 2019

Authors and Affiliations

  1. 1.Department of Nuclear Medicine and Molecular ImagingUniversity of Groningen, University Medical CenterGroningenThe Netherlands
  2. 2.Department of Radiation OncologyAffiliated Hospital of Yangzhou UniversityYangzhouChina
  3. 3.Division of Radiopharmaceutical Sciences, Department of Radiology, Weill Cornell Medical CollegeCornell UniversityNew YorkUSA
  4. 4.Division of Nuclear Medicine and Molecular ImagingGeneva University HospitalGenevaSwitzerland
  5. 5.Geneva University Neurocenter, University of GenevaGenevaSwitzerland
  6. 6.Department of Nuclear MedicineUniversity of Southern DenmarkOdenseDenmark

Personalised recommendations